My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > PCI-32765 (IBRUTINIB)

PCI-32765 (IBRUTINIB)

Ibrutinib

Catalog No. Product Name Size List Price (US$) Quantity
APIM050220 PCI-32765 (IBRUTINIB) 10 mg 85.00
APIM050220 PCI-32765 (IBRUTINIB) 50mg 135.00
APIM050220 PCI-32765 (IBRUTINIB) 100 mg 225.00
APIM050220 PCI-32765 (IBRUTINIB) 200 mg 335.00
APIM050220 PCI-32765 (IBRUTINIB) 500 mg 535.00
Description

Background Information:

B-cell antigen receptor (BCR) signaling is required for tumor expansion and proliferation. Bruton's Tyrosine Kinase (BTK) is an essential element of the BCR signaling pathway. Containment of BTK blocks BCR signaling and induces apoptosis. PCI-32765 is a potent, selective and orally bioavailable irreversible inhibitor of BTK with IC50 value of 0.5 nM.

Reference:

1. H. Zhang, et al, In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1, Br J Pharmacol. 2014 Dec;171(24):5845-57.
2. LA Honigberg, et al, The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80.* Our product PCI-32765 (Ibrutinib) has been through a thorough analysis and characterization – HPLC-MS, Chiral HPLC, NMR, optical rotation measurement (Degree and Direction) and Quantitative Elemental Analysis, a superior product in every aspect.

APIM050220: PCI-32765 (IBRUTINIB)

CAS No.: 936563-96-1.
Molecular Formula: C25H24N6O2.
Molecular Weight: 440.5.
Purity: >99.5% (HPLC at 214 and 254nm), 100% optical purity (Chiral HPLC), [α]20D = -128 o (c 0.87, Chloroform).
QC: HPLC-MS, 1HNMR, Chiral HPLC, and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.

Related Links

See our Privacy Policy